The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 1974, 113: 1288-1295.
Copyright © 1974 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tom, B. H.
Right arrow Articles by Kahan, B. D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Tom, B. H.
Right arrow Articles by Kahan, B. D.

Leukocyte Aggregation: An in Vitro Assay for Cell-Mediated Immunity1

Baldwin H. Tom, Milda M. Jakstys and Barry D. Kahan

From the Laboratory of Surgical Immunology, Departments of Surgery and Physiology, Northwestern University Medical Center and Veterans Administration Research Hospital, Chicago, Illinois 60611

Abstract

An in vitro leukocyte-aggregation assay was developed to assess cell-mediated immune reactivity by hosts against their allotransplants. The assay, which measures the adhesion of host leukocytes to target cells, is caused by a specific recognition of donor antigens by sensitized lymphocytes. The formation of aggregates may reflect the release of chemotactic and migration inhibition factors following recognition of specific target cell antigens, thereby attracting nonimmune bystander cells to the reaction foci. The test is simple to perform, brief, and requires small amounts of materials. Analysis of the patterns of reactivity of host cells suggests that the immunological specificity of the recognition event is consistent with the HL-A system in 80% of cases. Instances of disparities between predicted and observed reactions were attributed to lack of host sensitization, differences between serological and cellular HL-A cross-reactivities, and the potential participation of other histocompatibility systems.

Footnotes

1 Supported by grants from the National Institutes of Health (RO-1-CA 14694 and R 26-CA-15434), the American Cancer Society, and the Chicago and Illinois Heart Association (A-73-3).







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1974 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1974 by The American Association of Immunologists, Inc. All rights reserved.